http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2015102772-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517 |
| filingDate | 2013-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2015102772-A |
| titleOfInvention | Benzodiazelipas for small cell lung cancer |
| abstract | 1. Compound 2 - [(4S) -6- (4-chlorophenyl) -1-methyl-8- (methyloxy) -4H- [1,2,4] triazolo [4,3-a] [1,4] benzodiazepin-4-yl] -N-ethylacetamide or a pharmaceutically acceptable salt thereof for use in the treatment of small cell lung cancer. A compound according to claim 1 in the form of a free base. 3. A method for treating small cell lung cancer in a subject in need thereof, comprising administering a therapeutically effective amount of 2 - [(4S) -6- (4-chlorophenyl) -1-methyl-8- (methyloxy) -4H- [1,2,4 ] triazolo [4,3-a] [1,4] benzodiazepin-4-yl] -N-ethylacetamide or a pharmaceutically acceptable salt thereof. The treatment method of claim 3, wherein the subject is a human. A pharmaceutical composition containing 2 - [(4S) -6- (4-chlorophenyl) -1-methyl-8- (methyloxy) -4H- [1,2,4] triazolo [4,3-a] [1,4 ] benzodiazepin-4-yl] -N-ethylacetamide or a pharmaceutically acceptable salt thereof, for use in the treatment of small cell lung cancer. The pharmaceutical composition according to claim 5, adapted for oral administration. Combined pharmaceutical product containing 2 - [(4S) -6- (4-chlorophenyl) -1-methyl-8- (methyloxy) -4H- [1,2,4] triazolo [4,3-a] [1, 4] benzodiazepin-4-yl] -N-ethylacetamide or a pharmaceutically acceptable salt thereof, as defined in paragraph 1 or paragraph 2, together with one or more additional therapeutically active agents suitable for use in the treatment of small cell lung cancer. |
| priorityDate | 2012-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426279332 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46943432 |
Total number of triples: 17.